CAR-T Continues to Show Promise for Pleural Mesothelioma Patients

A recently completed phase I trial conducted by researchers at Memorial Sloan Kettering Cancer center has shown a safe and positive response in mesothelioma patients, according to a report published in the journal Cancer Discovery. After scientists administered chimeric antigen receptor T-cell (CAR-T) therapy followed by Keytruda, 83 percent of patients were alive one year later.

Cause of Death: Mesothelioma

If you see “Cause of Death: Mesothelioma” on a death certificate, you may be wondering what it is or how this happened. Mesothelioma is a rare cancer most often associated with asbestos exposure. In most cases, a company or employer can be held accountable for exposure and resulting illness. What Is Mesothelioma? Mesothelioma is a

Mesothelioma Allies Encouraged as EPA and Asbestos Advocacy Group Reach Agreement

It’s been a long time coming, but the Environmental Protection Agency (EPA) and advocacy groups including the Asbestos Disease Awareness Organization (ADAO) have reached an important agreement regarding the mineral that causes mesothelioma. Activists have been pushing for a comprehensive second risk evaluation for asbestos, and are hailing the new consensus as a victory. 

Checkmate-743 Trial Shows Durable Overall Survival in Malignant Pleural Mesothelioma

Despite the best efforts of scientists around the globe, malignant pleural mesothelioma continues to carry an extremely poor prognosis, with a five-year survival rate of just 10%. Still, patients are benefitting from research. The Checkmate-743 trial recently yielded a report of increased durable overall survival in mesothelioma from the immunotherapy combination of nivolumab and ipilimumab.

Miami Study Finds Variability in Income Levels and Survival in Mesothelioma Patients

In assessing potential risk factors and outcomes for patients diagnosed with malignant mesothelioma, there have long been questions about whether a patient’s socioeconomic status plays a role in their access to quality care. A study conducted by researchers from the University of Miami’s Sylvester Comprehensive Cancer Center examined the issue and found significant variability.

Study Shows Significant Mesothelioma Survival Boost With Surgery

The role of surgery in the treatment of mesothelioma continues to generate controversy, but researchers in one of the largest studies of surgery’s role in mesothelioma treatment have concluded that combining tumor removal with chemotherapy has the single greatest positive impact on extending patient survival. Speaking to attendees of the virtual World Conference on Lung

Researchers Cautiously Optimistic About “Triplet” Therapy for Malignant Mesothelioma

Researchers from the MD Anderson Cancer Center in Houston demonstrated cautious optimism about their recent study of a triple neoadjuvant regimen using cisplatin, pemetrexed, and atezolizumab. Speaking at the virtual World Congress on Lung Cancer, the scientists reported that sixty percent of eligible patients who received the triplet therapy moved on to surgical resection or

Mesothelioma in Mexico

Asbestos use and exposure continue to be problems in Mexico. It has led to numerous cases of mesothelioma and other asbestos illnesses and many resulting deaths. Mexico has yet to ban asbestos, and powerful lobbyists continue to work against a ban. Facts About Mesothelioma and Asbestos in Mexico Mexico imports tons of asbestos and uses

High Rate of COVID-19 and COVID-19 Deaths in Mesothelioma Patients

A recently released study of the impact of COVID-19 on Spanish mesothelioma patients revealed that nearly one in five contracted the disease, and of those affected, three out of four died. The research was presented at the IASLC 2021 World Conference on Lung Cancer.

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now